GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nhlh1
|
ENSRNOG00000005166 | nescient helix loop helix 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nhlh1 | rn6_v1_chr13_-_90443157_90443157 | 0.53 | 1.5e-24 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_176666282 | 46.19 |
ENSRNOT00000016947
|
Eef1a2
|
eukaryotic translation elongation factor 1 alpha 2 |
chr8_+_111600532 | 42.44 |
ENSRNOT00000081952
|
Rab6b
|
RAB6B, member RAS oncogene family |
chr1_+_265298868 | 39.63 |
ENSRNOT00000023278
|
Dpcd
|
deleted in primary ciliary dyskinesia |
chr5_-_109651730 | 39.43 |
ENSRNOT00000093032
|
Elavl2
|
ELAV like RNA binding protein 2 |
chr1_-_89560719 | 37.82 |
ENSRNOT00000028653
|
Scn1b
|
sodium voltage-gated channel beta subunit 1 |
chr18_+_79406381 | 37.47 |
ENSRNOT00000022303
ENSRNOT00000058295 ENSRNOT00000058296 ENSRNOT00000022280 |
Mbp
|
myelin basic protein |
chr13_+_92569785 | 36.72 |
ENSRNOT00000082700
|
Fmn2
|
formin 2 |
chr15_+_44799334 | 32.93 |
ENSRNOT00000018599
|
Nefl
|
neurofilament light |
chr6_-_42473738 | 31.56 |
ENSRNOT00000033327
|
Kcnf1
|
potassium voltage-gated channel modifier subfamily F member 1 |
chr11_+_72705129 | 30.13 |
ENSRNOT00000073330
|
Apod
|
apolipoprotein D |
chr7_-_145154131 | 30.05 |
ENSRNOT00000055271
|
Ppp1r1a
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
chr8_+_97291580 | 29.95 |
ENSRNOT00000018794
|
Rasgrf1
|
RAS protein-specific guanine nucleotide-releasing factor 1 |
chr1_-_31055453 | 29.25 |
ENSRNOT00000031083
|
Soga3
|
SOGA family member 3 |
chr2_-_119537837 | 28.67 |
ENSRNOT00000015200
|
Pex5l
|
peroxisomal biogenesis factor 5-like |
chr10_-_8654892 | 28.64 |
ENSRNOT00000066534
|
Rbfox1
|
RNA binding protein, fox-1 homolog 1 |
chr7_+_11556192 | 28.64 |
ENSRNOT00000046078
|
Diras1
|
DIRAS family GTPase 1 |
chr4_-_147163467 | 27.86 |
ENSRNOT00000010748
|
Timp4
|
tissue inhibitor of metalloproteinase 4 |
chrX_+_39711201 | 27.73 |
ENSRNOT00000080512
ENSRNOT00000009802 |
Cnksr2
|
connector enhancer of kinase suppressor of Ras 2 |
chr1_+_78876205 | 27.71 |
ENSRNOT00000022610
|
Pnmal2
|
paraneoplastic Ma antigen family-like 2 |
chr3_-_176644951 | 27.71 |
ENSRNOT00000049961
|
Kcnq2
|
potassium voltage-gated channel subfamily Q member 2 |
chr11_+_57505005 | 27.64 |
ENSRNOT00000002942
|
LOC103693564
|
transgelin-3 |
chr5_-_109621170 | 27.61 |
ENSRNOT00000093007
|
Elavl2
|
ELAV like RNA binding protein 2 |
chr1_-_89559960 | 27.28 |
ENSRNOT00000092133
|
Scn1b
|
sodium voltage-gated channel beta subunit 1 |
chr18_-_1946840 | 27.26 |
ENSRNOT00000041878
|
Abhd3
|
abhydrolase domain containing 3 |
chr10_-_8498422 | 27.14 |
ENSRNOT00000082332
|
Rbfox1
|
RNA binding protein, fox-1 homolog 1 |
chr14_-_80169431 | 27.13 |
ENSRNOT00000079769
ENSRNOT00000058315 |
Ablim2
|
actin binding LIM protein family, member 2 |
chr1_+_36185916 | 26.98 |
ENSRNOT00000041762
|
Ube2ql1
|
ubiquitin-conjugating enzyme E2Q family-like 1 |
chr17_+_13670520 | 26.60 |
ENSRNOT00000019442
|
Shc3
|
SHC adaptor protein 3 |
chr18_+_27632786 | 26.46 |
ENSRNOT00000073564
ENSRNOT00000078969 |
Reep2
|
receptor accessory protein 2 |
chr3_+_35014538 | 26.36 |
ENSRNOT00000006341
|
Kif5c
|
kinesin family member 5C |
chr15_+_33600102 | 26.27 |
ENSRNOT00000022664
|
Cmtm5
|
CKLF-like MARVEL transmembrane domain containing 5 |
chr1_+_105349069 | 26.27 |
ENSRNOT00000056030
|
Nell1
|
neural EGFL like 1 |
chr7_-_140483693 | 26.02 |
ENSRNOT00000089060
|
Ddn
|
dendrin |
chr14_-_112946204 | 25.53 |
ENSRNOT00000056813
|
LOC103690141
|
coiled-coil domain-containing protein 85A-like |
chr15_+_33600337 | 25.47 |
ENSRNOT00000075965
|
Cmtm5
|
CKLF-like MARVEL transmembrane domain containing 5 |
chr5_-_74029238 | 25.39 |
ENSRNOT00000031432
|
Frrs1l
|
ferric-chelate reductase 1-like |
chr7_+_142575672 | 25.33 |
ENSRNOT00000080923
ENSRNOT00000008160 |
Scn8a
|
sodium voltage-gated channel alpha subunit 8 |
chr8_-_82641536 | 25.33 |
ENSRNOT00000014491
|
Scg3
|
secretogranin III |
chr16_+_26906716 | 25.09 |
ENSRNOT00000064297
|
Cpe
|
carboxypeptidase E |
chr9_+_73493027 | 24.58 |
ENSRNOT00000074427
ENSRNOT00000089478 |
Unc80
|
unc-80 homolog, NALCN activator |
chr4_+_136512201 | 24.49 |
ENSRNOT00000051645
|
Cntn6
|
contactin 6 |
chr6_+_3657325 | 24.01 |
ENSRNOT00000010927
|
Tmem178a
|
transmembrane protein 178A |
chr3_+_154863072 | 24.00 |
ENSRNOT00000055200
|
Snhg11
|
small nucleolar RNA host gene 11 |
chr12_-_12025549 | 23.84 |
ENSRNOT00000001331
|
Nptx2
|
neuronal pentraxin 2 |
chr16_-_59366824 | 23.67 |
ENSRNOT00000015062
|
RGD1304810
|
similar to 6430573F11Rik protein |
chr19_-_43596801 | 23.64 |
ENSRNOT00000025625
|
Fa2h
|
fatty acid 2-hydroxylase |
chr3_-_129357348 | 23.54 |
ENSRNOT00000084829
ENSRNOT00000007410 |
Pak7
|
p21 (RAC1) activated kinase 7 |
chr6_+_132246602 | 23.50 |
ENSRNOT00000009896
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr2_-_231521052 | 23.43 |
ENSRNOT00000089534
ENSRNOT00000080470 ENSRNOT00000084756 |
Ank2
|
ankyrin 2 |
chr6_-_105097054 | 23.28 |
ENSRNOT00000048606
|
Slc8a3
|
solute carrier family 8 member A3 |
chr1_+_78800754 | 23.18 |
ENSRNOT00000084601
|
Dact3
|
dishevelled-binding antagonist of beta-catenin 3 |
chr3_-_2534663 | 23.07 |
ENSRNOT00000049297
ENSRNOT00000044246 |
Grin1
|
glutamate ionotropic receptor NMDA type subunit 1 |
chr9_-_92291220 | 23.04 |
ENSRNOT00000093357
|
Dner
|
delta/notch-like EGF repeat containing |
chr14_+_99529284 | 22.80 |
ENSRNOT00000006897
ENSRNOT00000067134 |
Vstm2a
|
V-set and transmembrane domain containing 2A |
chr2_+_112868707 | 22.77 |
ENSRNOT00000017805
|
Nceh1
|
neutral cholesterol ester hydrolase 1 |
chr4_+_33638709 | 22.58 |
ENSRNOT00000009888
ENSRNOT00000034719 ENSRNOT00000052333 |
Tac1
|
tachykinin, precursor 1 |
chr8_-_36760742 | 22.06 |
ENSRNOT00000017307
|
Ddx25
|
DEAD-box helicase 25 |
chr3_+_110574417 | 21.98 |
ENSRNOT00000031231
|
Disp2
|
dispatched RND transporter family member 2 |
chr8_-_115981910 | 21.63 |
ENSRNOT00000019867
|
Dock3
|
dedicator of cyto-kinesis 3 |
chr7_-_121029754 | 21.54 |
ENSRNOT00000004703
|
Nptxr
|
neuronal pentraxin receptor |
chr5_+_147323240 | 21.52 |
ENSRNOT00000047152
|
Fndc5
|
fibronectin type III domain containing 5 |
chr8_+_116715755 | 21.49 |
ENSRNOT00000090239
|
Camkv
|
CaM kinase-like vesicle-associated |
chr2_+_115739813 | 21.46 |
ENSRNOT00000085452
|
Slc7a14
|
solute carrier family 7, member 14 |
chr19_-_26053762 | 21.31 |
ENSRNOT00000004646
|
MAST1
|
microtubule associated serine/threonine kinase 1 |
chr4_+_147037179 | 21.10 |
ENSRNOT00000011292
|
Syn2
|
synapsin II |
chr6_-_67085390 | 21.05 |
ENSRNOT00000083277
|
Nova1
|
NOVA alternative splicing regulator 1 |
chrX_+_6791136 | 20.93 |
ENSRNOT00000003984
|
LOC100909913
|
norrin-like |
chrX_-_142131545 | 20.86 |
ENSRNOT00000077402
|
Fgf13
|
fibroblast growth factor 13 |
chr5_-_168734296 | 20.83 |
ENSRNOT00000066120
|
Camta1
|
calmodulin binding transcription activator 1 |
chr1_-_89560469 | 20.46 |
ENSRNOT00000079091
|
Scn1b
|
sodium voltage-gated channel beta subunit 1 |
chr10_-_97582188 | 20.38 |
ENSRNOT00000005076
|
Rgs9
|
regulator of G-protein signaling 9 |
chr8_+_49441106 | 20.30 |
ENSRNOT00000030152
|
Scn4b
|
sodium voltage-gated channel beta subunit 4 |
chrX_+_114929029 | 20.12 |
ENSRNOT00000006459
|
Pak3
|
p21 (RAC1) activated kinase 3 |
chr3_+_56861396 | 19.92 |
ENSRNOT00000000008
ENSRNOT00000084375 |
Gad1
|
glutamate decarboxylase 1 |
chr14_-_80732010 | 19.80 |
ENSRNOT00000012322
|
Adra2c
|
adrenoceptor alpha 2C |
chr10_-_15928169 | 19.75 |
ENSRNOT00000028069
|
Nsg2
|
neuron specific gene family member 2 |
chrX_+_82143789 | 19.55 |
ENSRNOT00000003724
|
Pou3f4
|
POU class 3 homeobox 4 |
chr12_-_36398206 | 19.45 |
ENSRNOT00000090944
ENSRNOT00000058492 |
Tmem132b
|
transmembrane protein 132B |
chr3_-_147143576 | 19.36 |
ENSRNOT00000091811
ENSRNOT00000012727 |
Snph
|
syntaphilin |
chr10_-_103816287 | 19.11 |
ENSRNOT00000004477
|
Grin2c
|
glutamate ionotropic receptor NMDA type subunit 2C |
chr7_+_123043503 | 18.88 |
ENSRNOT00000026258
ENSRNOT00000086355 |
Tef
|
TEF, PAR bZIP transcription factor |
chr1_+_173607101 | 18.73 |
ENSRNOT00000074636
|
Tub
|
tubby bipartite transcription factor |
chrX_+_23081125 | 18.52 |
ENSRNOT00000071639
|
AABR07037520.1
|
|
chr2_-_21698937 | 18.31 |
ENSRNOT00000080165
|
AABR07007642.1
|
|
chr5_+_156876706 | 18.26 |
ENSRNOT00000021864
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr18_-_69944632 | 18.16 |
ENSRNOT00000047271
|
Mapk4
|
mitogen-activated protein kinase 4 |
chr5_+_146383942 | 18.15 |
ENSRNOT00000078588
|
Csmd2
|
CUB and Sushi multiple domains 2 |
chr9_-_28973246 | 17.94 |
ENSRNOT00000091865
ENSRNOT00000015453 |
Rims1
|
regulating synaptic membrane exocytosis 1 |
chr3_-_105279462 | 17.90 |
ENSRNOT00000010679
|
Scg5
|
secretogranin V |
chr4_-_117268178 | 17.77 |
ENSRNOT00000043201
ENSRNOT00000084049 |
Fbxo41
|
F-box protein 41 |
chr12_+_47193964 | 17.67 |
ENSRNOT00000001552
ENSRNOT00000039281 |
Cabp1
|
calcium binding protein 1 |
chr18_+_52215682 | 17.67 |
ENSRNOT00000037901
|
Megf10
|
multiple EGF-like domains 10 |
chr9_-_46401911 | 17.50 |
ENSRNOT00000046557
|
Creg2
|
cellular repressor of E1A-stimulated genes 2 |
chr4_-_118198029 | 17.49 |
ENSRNOT00000022532
|
Pcyox1
|
prenylcysteine oxidase 1 |
chr2_+_54191538 | 17.44 |
ENSRNOT00000019524
|
Plcxd3
|
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
chr10_-_103919605 | 17.41 |
ENSRNOT00000004718
|
Hid1
|
HID1 domain containing |
chr10_-_14056169 | 17.37 |
ENSRNOT00000017833
|
Syngr3
|
synaptogyrin 3 |
chr12_-_46920952 | 17.25 |
ENSRNOT00000001532
|
Msi1
|
musashi RNA-binding protein 1 |
chr1_-_260992291 | 17.19 |
ENSRNOT00000035415
ENSRNOT00000034758 |
Slit1
|
slit guidance ligand 1 |
chr16_+_48121430 | 17.15 |
ENSRNOT00000090839
|
Stox2
|
storkhead box 2 |
chr3_-_2534375 | 17.07 |
ENSRNOT00000037725
|
Grin1
|
glutamate ionotropic receptor NMDA type subunit 1 |
chr10_-_51669297 | 16.88 |
ENSRNOT00000071595
|
Arhgap44
|
Rho GTPase activating protein 44 |
chrX_+_106306795 | 16.69 |
ENSRNOT00000073661
|
Gprasp1
|
G protein-coupled receptor associated sorting protein 1 |
chr1_+_211351350 | 16.61 |
ENSRNOT00000082751
ENSRNOT00000030461 |
Jakmip3
|
janus kinase and microtubule interacting protein 3 |
chr2_-_172361779 | 16.28 |
ENSRNOT00000085876
|
Schip1
|
schwannomin interacting protein 1 |
chr2_-_179842547 | 16.26 |
ENSRNOT00000014170
|
Glrb
|
glycine receptor, beta |
chr8_-_23063041 | 16.20 |
ENSRNOT00000018416
|
Elavl3
|
ELAV like RNA binding protein 3 |
chr5_-_21345805 | 16.02 |
ENSRNOT00000081296
ENSRNOT00000007802 |
Car8
|
carbonic anhydrase 8 |
chr3_-_51054378 | 15.96 |
ENSRNOT00000089243
|
Grb14
|
growth factor receptor bound protein 14 |
chr17_+_7675531 | 15.94 |
ENSRNOT00000061187
|
Spock1
|
sparc/osteonectin, cwcv and kazal like domains proteoglycan 1 |
chr11_+_60072727 | 15.92 |
ENSRNOT00000090230
|
Tagln3
|
transgelin 3 |
chr7_+_12974169 | 15.86 |
ENSRNOT00000010555
|
C2cd4c
|
C2 calcium-dependent domain containing 4C |
chr12_+_49328977 | 15.84 |
ENSRNOT00000000898
|
Sgsm1
|
small G protein signaling modulator 1 |
chrX_-_63807810 | 15.81 |
ENSRNOT00000084632
|
Maged1
|
MAGE family member D1 |
chr1_-_73753128 | 15.75 |
ENSRNOT00000068459
|
Ttyh1
|
tweety family member 1 |
chr4_-_159654063 | 15.70 |
ENSRNOT00000091662
|
Tigar
|
TP53 induced glycolysis regulatory phosphatase |
chr9_+_41295909 | 15.69 |
ENSRNOT00000018935
|
Arhgef4
|
Rho guanine nucleotide exchange factor 4 |
chr14_-_112946875 | 15.62 |
ENSRNOT00000081981
|
LOC103690141
|
coiled-coil domain-containing protein 85A-like |
chr15_-_80713153 | 15.60 |
ENSRNOT00000063800
|
Klhl1
|
kelch-like family member 1 |
chr3_-_143063983 | 15.52 |
ENSRNOT00000006329
|
Napb
|
NSF attachment protein beta |
chr9_-_28972835 | 15.44 |
ENSRNOT00000086967
ENSRNOT00000079684 |
Rims1
|
regulating synaptic membrane exocytosis 1 |
chr1_+_264059374 | 15.42 |
ENSRNOT00000075397
|
Scd2
|
stearoyl-Coenzyme A desaturase 2 |
chr4_-_150244372 | 15.35 |
ENSRNOT00000047685
|
Ret
|
ret proto-oncogene |
chr12_+_2534212 | 15.32 |
ENSRNOT00000001399
|
Ctxn1
|
cortexin 1 |
chr2_+_210685197 | 15.25 |
ENSRNOT00000072342
|
NEWGENE_620381
|
glutathione S-transferase mu 3 |
chr6_+_132242328 | 15.19 |
ENSRNOT00000081088
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr1_-_100969560 | 15.13 |
ENSRNOT00000035908
|
Cpt1c
|
carnitine palmitoyltransferase 1c |
chr8_+_130416355 | 15.12 |
ENSRNOT00000026234
|
Klhl40
|
kelch-like family member 40 |
chr5_+_144634143 | 15.09 |
ENSRNOT00000075558
|
RGD1563072
|
similar to hypothetical protein FLJ38984 |
chr2_+_27905535 | 15.05 |
ENSRNOT00000022120
|
Fam169a
|
family with sequence similarity 169, member A |
chr3_+_111545007 | 14.93 |
ENSRNOT00000007247
|
Itpka
|
inositol-trisphosphate 3-kinase A |
chr3_-_148428494 | 14.90 |
ENSRNOT00000011350
|
Dusp15
|
dual specificity phosphatase 15 |
chr9_-_55673704 | 14.86 |
ENSRNOT00000066231
ENSRNOT00000081677 |
Tmeff2
|
transmembrane protein with EGF-like and two follistatin-like domains 2 |
chr7_-_12793711 | 14.85 |
ENSRNOT00000013762
|
Palm
|
paralemmin |
chr10_-_109224370 | 14.83 |
ENSRNOT00000005839
|
Aatk
|
apoptosis-associated tyrosine kinase |
chr2_+_28049217 | 14.77 |
ENSRNOT00000022144
|
Enc1
|
ectodermal-neural cortex 1 |
chrX_+_105239840 | 14.72 |
ENSRNOT00000039864
|
Drp2
|
dystrophin related protein 2 |
chr10_-_58834538 | 14.70 |
ENSRNOT00000020043
|
Slc13a5
|
solute carrier family 13 member 5 |
chr9_-_40008680 | 14.67 |
ENSRNOT00000016578
|
Khdrbs2
|
KH RNA binding domain containing, signal transduction associated 2 |
chr1_+_222311253 | 14.49 |
ENSRNOT00000028749
|
Macrod1
|
MACRO domain containing 1 |
chr14_-_84170835 | 14.48 |
ENSRNOT00000005646
|
Slc35e4
|
solute carrier family 35, member E4 |
chr5_-_139227196 | 14.47 |
ENSRNOT00000050941
|
Foxo6
|
forkhead box O6 |
chr20_+_2004052 | 14.46 |
ENSRNOT00000001008
|
Mog
|
myelin oligodendrocyte glycoprotein |
chr1_-_112811936 | 14.35 |
ENSRNOT00000093339
|
Gabrg3
|
gamma-aminobutyric acid type A receptor gamma 3 subunit |
chr8_-_53146953 | 14.28 |
ENSRNOT00000045356
|
Zbtb16
|
zinc finger and BTB domain containing 16 |
chr2_-_144323254 | 14.22 |
ENSRNOT00000018780
|
Sertm1
|
serine-rich and transmembrane domain containing 1 |
chr16_+_53998560 | 14.13 |
ENSRNOT00000077188
ENSRNOT00000013463 |
Asah1
|
N-acylsphingosine amidohydrolase 1 |
chr19_+_752151 | 14.02 |
ENSRNOT00000075978
|
Dync1li2
|
dynein, cytoplasmic 1 light intermediate chain 2 |
chr1_+_266952561 | 14.02 |
ENSRNOT00000076452
|
Neurl1
|
neuralized E3 ubiquitin protein ligase 1 |
chr7_+_145117951 | 13.93 |
ENSRNOT00000055272
|
Pde1b
|
phosphodiesterase 1B |
chr3_+_148510779 | 13.84 |
ENSRNOT00000012156
|
Xkr7
|
XK related 7 |
chr16_-_20807070 | 13.74 |
ENSRNOT00000072536
|
Comp
|
cartilage oligomeric matrix protein |
chr3_+_3325770 | 13.70 |
ENSRNOT00000023542
|
Kcnt1
|
potassium sodium-activated channel subfamily T member 1 |
chr8_-_115167486 | 13.68 |
ENSRNOT00000033018
|
Gpr62
|
G protein-coupled receptor 62 |
chr10_-_45534570 | 13.67 |
ENSRNOT00000058362
|
Gjc2
|
gap junction protein, gamma 2 |
chr10_+_47281786 | 13.63 |
ENSRNOT00000089123
|
Kcnj12
|
potassium voltage-gated channel subfamily J member 12 |
chr1_+_222310920 | 13.63 |
ENSRNOT00000091465
|
Macrod1
|
MACRO domain containing 1 |
chr5_-_164971903 | 13.58 |
ENSRNOT00000067059
|
Fbxo44
|
F-box protein 44 |
chr7_+_20262680 | 13.53 |
ENSRNOT00000046378
|
LOC300308
|
similar to hypothetical protein 4930509O22 |
chr11_-_87449940 | 13.52 |
ENSRNOT00000002560
|
Slc7a4
|
solute carrier family 7, member 4 |
chr13_+_101181994 | 13.52 |
ENSRNOT00000052407
|
Susd4
|
sushi domain containing 4 |
chr2_+_119197239 | 13.48 |
ENSRNOT00000048030
|
Usp13
|
ubiquitin specific peptidase 13 |
chr15_-_33775109 | 13.35 |
ENSRNOT00000033722
|
Jph4
|
junctophilin 4 |
chr10_+_90731865 | 13.31 |
ENSRNOT00000064429
|
Adam11
|
ADAM metallopeptidase domain 11 |
chr7_-_116255167 | 13.29 |
ENSRNOT00000038109
ENSRNOT00000041774 |
Cyp11b2
|
cytochrome P450, family 11, subfamily b, polypeptide 2 |
chrX_-_29648359 | 13.12 |
ENSRNOT00000086721
ENSRNOT00000006777 |
Gpm6b
|
glycoprotein m6b |
chr7_+_123168811 | 13.04 |
ENSRNOT00000007091
|
Csdc2
|
cold shock domain containing C2 |
chr5_+_1417478 | 13.01 |
ENSRNOT00000008153
ENSRNOT00000085564 |
Jph1
|
junctophilin 1 |
chr1_+_72545596 | 13.00 |
ENSRNOT00000022698
|
Shisa7
|
shisa family member 7 |
chr10_-_61361250 | 12.85 |
ENSRNOT00000092203
|
Rap1gap2
|
RAP1 GTPase activating protein 2 |
chr14_-_82048251 | 12.76 |
ENSRNOT00000074734
|
Nat8l
|
N-acetyltransferase 8-like |
chr7_-_117151694 | 12.68 |
ENSRNOT00000051294
|
Nrbp2
|
nuclear receptor binding protein 2 |
chr10_-_108691367 | 12.64 |
ENSRNOT00000005067
|
Nptx1
|
neuronal pentraxin 1 |
chr9_+_82700468 | 12.59 |
ENSRNOT00000027227
|
Inha
|
inhibin alpha subunit |
chr1_-_162300515 | 12.58 |
ENSRNOT00000031161
|
Usp35
|
ubiquitin specific peptidase 35 |
chr14_+_60764409 | 12.57 |
ENSRNOT00000005168
|
Lgi2
|
leucine-rich repeat LGI family, member 2 |
chr4_-_71713063 | 12.45 |
ENSRNOT00000059447
|
Fam131b
|
family with sequence similarity 131, member B |
chr14_+_81725513 | 12.42 |
ENSRNOT00000020154
|
Zfyve28
|
zinc finger FYVE-type containing 28 |
chr7_+_122456799 | 12.37 |
ENSRNOT00000025564
|
Mchr1
|
melanin-concentrating hormone receptor 1 |
chr10_-_74376270 | 12.34 |
ENSRNOT00000079311
|
Gdpd1
|
glycerophosphodiester phosphodiesterase domain containing 1 |
chr3_+_22640545 | 12.32 |
ENSRNOT00000064507
ENSRNOT00000014452 |
Lhx2
|
LIM homeobox 2 |
chr11_+_31428358 | 12.28 |
ENSRNOT00000002827
|
Olig1
|
oligodendrocyte transcription factor 1 |
chr5_-_82168347 | 12.27 |
ENSRNOT00000084959
ENSRNOT00000084147 |
Astn2
|
astrotactin 2 |
chr2_+_228544418 | 12.19 |
ENSRNOT00000013030
|
Tram1l1
|
translocation associated membrane protein 1-like 1 |
chr4_-_11497531 | 12.16 |
ENSRNOT00000078799
|
Magi2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
chr9_+_29984077 | 12.16 |
ENSRNOT00000075592
|
B3gat2
|
beta-1,3-glucuronyltransferase 2 |
chr15_-_33576331 | 12.15 |
ENSRNOT00000021851
|
Slc22a17
|
solute carrier family 22, member 17 |
chr17_+_15924048 | 12.14 |
ENSRNOT00000050696
|
Wnk2
|
WNK lysine deficient protein kinase 2 |
chr4_-_176720012 | 12.09 |
ENSRNOT00000017965
|
Ldhb
|
lactate dehydrogenase B |
chr20_+_3558827 | 12.06 |
ENSRNOT00000088130
|
Ddr1
|
discoidin domain receptor tyrosine kinase 1 |
chr3_-_176465162 | 12.04 |
ENSRNOT00000048807
|
Nkain4
|
Sodium/potassium transporting ATPase interacting 4 |
chr10_+_47282208 | 11.97 |
ENSRNOT00000057953
|
Kcnj12
|
potassium voltage-gated channel subfamily J member 12 |
chr4_+_108301129 | 11.94 |
ENSRNOT00000007993
|
LRRTM1
|
leucine rich repeat transmembrane neuronal 1 |
chr8_+_56179637 | 11.83 |
ENSRNOT00000035989
|
Arhgap20
|
Rho GTPase activating protein 20 |
chr3_-_148428288 | 11.83 |
ENSRNOT00000072663
|
Dusp15
|
dual specificity phosphatase 15 |
chr12_+_24473981 | 11.77 |
ENSRNOT00000001973
|
Fzd9
|
frizzled class receptor 9 |
chrX_+_157150655 | 11.74 |
ENSRNOT00000090795
|
Pnck
|
pregnancy up-regulated nonubiquitous CaM kinase |
chr19_+_784618 | 11.71 |
ENSRNOT00000014749
|
Cmtm4
|
CKLF-like MARVEL transmembrane domain containing 4 |
chr1_-_143278485 | 11.59 |
ENSRNOT00000026009
|
Cpeb1
|
cytoplasmic polyadenylation element binding protein 1 |
chr20_+_20105047 | 11.57 |
ENSRNOT00000082181
|
Ank3
|
ankyrin 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.1 | 85.6 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
15.2 | 45.7 | GO:0021678 | third ventricle development(GO:0021678) |
14.8 | 44.5 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
13.4 | 40.1 | GO:1900673 | olefin metabolic process(GO:1900673) |
12.5 | 37.5 | GO:1904685 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) positive regulation of metalloendopeptidase activity(GO:1904685) |
11.1 | 33.4 | GO:0031632 | positive regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031632) |
11.0 | 32.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
10.0 | 30.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
8.7 | 26.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
8.6 | 17.2 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
7.4 | 29.5 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
7.0 | 28.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
6.6 | 26.4 | GO:0098963 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
6.4 | 12.8 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
6.4 | 19.1 | GO:0033058 | directional locomotion(GO:0033058) |
6.1 | 24.5 | GO:0098886 | modification of dendritic spine(GO:0098886) |
5.9 | 23.4 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
5.8 | 17.4 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
5.7 | 28.7 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
5.7 | 17.0 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
5.1 | 15.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
5.0 | 25.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
5.0 | 25.1 | GO:2000173 | insulin processing(GO:0030070) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
5.0 | 14.9 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
4.9 | 19.8 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
4.9 | 24.7 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
4.9 | 14.7 | GO:0071422 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
4.9 | 4.9 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
4.6 | 22.8 | GO:0070343 | white fat cell proliferation(GO:0070343) positive regulation of fat cell proliferation(GO:0070346) regulation of white fat cell proliferation(GO:0070350) |
4.5 | 13.5 | GO:0045959 | negative regulation of complement activation, classical pathway(GO:0045959) |
4.1 | 16.3 | GO:0031179 | peptide modification(GO:0031179) |
4.1 | 12.2 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
4.0 | 32.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
4.0 | 19.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
3.9 | 15.7 | GO:1902689 | negative regulation of fermentation(GO:1901003) negative regulation of NAD metabolic process(GO:1902689) negative regulation of glucose catabolic process to lactate via pyruvate(GO:1904024) |
3.9 | 11.8 | GO:1990523 | bone regeneration(GO:1990523) |
3.9 | 15.4 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
3.8 | 19.2 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
3.7 | 11.2 | GO:0050883 | medulla oblongata development(GO:0021550) musculoskeletal movement, spinal reflex action(GO:0050883) |
3.7 | 22.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
3.7 | 14.8 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
3.7 | 14.7 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
3.7 | 18.3 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
3.4 | 10.3 | GO:0046038 | guanine salvage(GO:0006178) GMP catabolic process(GO:0046038) guanine biosynthetic process(GO:0046099) |
3.4 | 13.5 | GO:0036506 | protein K29-linked deubiquitination(GO:0035523) maintenance of unfolded protein(GO:0036506) protein K6-linked deubiquitination(GO:0044313) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
3.3 | 6.6 | GO:0009405 | pathogenesis(GO:0009405) |
3.3 | 19.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
3.3 | 16.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
3.2 | 9.7 | GO:1903445 | protein transport from ciliary membrane to plasma membrane(GO:1903445) |
3.1 | 43.7 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
3.1 | 9.2 | GO:0072054 | renal outer medulla development(GO:0072054) |
3.1 | 33.7 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
3.0 | 9.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
3.0 | 9.1 | GO:0002086 | diaphragm contraction(GO:0002086) |
3.0 | 42.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
3.0 | 9.0 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
3.0 | 23.9 | GO:0032342 | aldosterone biosynthetic process(GO:0032342) |
3.0 | 20.9 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
3.0 | 17.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
2.9 | 26.5 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
2.9 | 55.8 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
2.9 | 11.6 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
2.8 | 2.8 | GO:0007386 | compartment pattern specification(GO:0007386) |
2.8 | 22.6 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
2.8 | 19.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
2.8 | 16.7 | GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051343) |
2.8 | 5.6 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
2.8 | 11.2 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
2.8 | 5.6 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
2.6 | 13.1 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.6 | 23.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
2.5 | 12.5 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
2.5 | 27.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
2.5 | 14.9 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
2.4 | 4.7 | GO:0035926 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) |
2.3 | 11.7 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
2.3 | 9.3 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
2.3 | 16.2 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
2.3 | 23.0 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
2.3 | 4.6 | GO:0014016 | neuroblast differentiation(GO:0014016) |
2.2 | 9.0 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
2.2 | 6.7 | GO:0010265 | SCF complex assembly(GO:0010265) |
2.2 | 6.6 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) Spemann organizer formation(GO:0060061) canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
2.2 | 17.7 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
2.2 | 6.5 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
2.2 | 6.5 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
2.2 | 6.5 | GO:1903774 | multivesicular body assembly(GO:0036258) positive regulation of viral budding via host ESCRT complex(GO:1903774) |
2.1 | 6.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
2.1 | 8.3 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
2.0 | 6.1 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
2.0 | 12.2 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.0 | 6.1 | GO:1990402 | embryonic liver development(GO:1990402) |
2.0 | 6.0 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
2.0 | 59.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
2.0 | 4.0 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
2.0 | 11.9 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
2.0 | 6.0 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
2.0 | 2.0 | GO:1900453 | negative regulation of long term synaptic depression(GO:1900453) |
1.9 | 5.7 | GO:0015960 | MAPK import into nucleus(GO:0000189) diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
1.9 | 22.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
1.9 | 30.0 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
1.9 | 13.0 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
1.8 | 23.9 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
1.8 | 5.5 | GO:0010986 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
1.8 | 10.7 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
1.7 | 13.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.7 | 6.6 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
1.7 | 5.0 | GO:0071529 | cementum mineralization(GO:0071529) |
1.7 | 5.0 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
1.7 | 6.6 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
1.6 | 4.9 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
1.6 | 6.4 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
1.6 | 4.8 | GO:0006435 | prolyl-tRNA aminoacylation(GO:0006433) threonyl-tRNA aminoacylation(GO:0006435) |
1.6 | 4.8 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
1.6 | 15.8 | GO:0006657 | CDP-choline pathway(GO:0006657) |
1.6 | 3.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.6 | 10.9 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
1.5 | 7.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.5 | 33.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.5 | 4.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.5 | 4.6 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
1.5 | 3.0 | GO:1901963 | Wnt signaling pathway involved in forebrain neuroblast division(GO:0021874) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) |
1.5 | 61.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
1.5 | 11.7 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.5 | 27.7 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
1.4 | 7.2 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
1.4 | 5.8 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
1.4 | 8.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.4 | 18.6 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
1.4 | 18.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
1.4 | 2.8 | GO:2000974 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
1.4 | 12.6 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
1.4 | 11.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.4 | 9.6 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
1.3 | 4.0 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
1.3 | 2.7 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
1.3 | 4.0 | GO:0006552 | leucine catabolic process(GO:0006552) |
1.3 | 6.6 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
1.3 | 9.0 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.3 | 3.9 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.3 | 9.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.3 | 17.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
1.2 | 5.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.2 | 5.0 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
1.2 | 6.0 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
1.2 | 22.8 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
1.2 | 15.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.2 | 2.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
1.2 | 3.5 | GO:0097187 | dentinogenesis(GO:0097187) |
1.1 | 14.8 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
1.1 | 3.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
1.1 | 11.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.1 | 6.7 | GO:0006868 | glutamine transport(GO:0006868) |
1.1 | 16.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.1 | 5.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
1.1 | 5.4 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
1.1 | 6.5 | GO:0030222 | eosinophil differentiation(GO:0030222) |
1.1 | 13.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.0 | 11.5 | GO:0007616 | long-term memory(GO:0007616) |
1.0 | 5.2 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
1.0 | 14.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.0 | 9.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.0 | 25.6 | GO:0010107 | potassium ion import(GO:0010107) |
1.0 | 13.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.0 | 3.0 | GO:0071387 | cellular response to cortisol stimulus(GO:0071387) |
1.0 | 6.0 | GO:0006449 | regulation of translational termination(GO:0006449) positive regulation of translational elongation(GO:0045901) |
1.0 | 3.0 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
1.0 | 2.9 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.0 | 2.9 | GO:0072021 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
1.0 | 4.8 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.0 | 5.8 | GO:0015808 | L-alanine transport(GO:0015808) |
1.0 | 4.8 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.0 | 1.9 | GO:0007172 | signal complex assembly(GO:0007172) |
1.0 | 10.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.9 | 3.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.9 | 14.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.9 | 3.7 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.9 | 30.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.9 | 1.8 | GO:0060913 | sensory system development(GO:0048880) cardiac cell fate determination(GO:0060913) |
0.9 | 7.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.9 | 5.5 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.9 | 13.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.9 | 4.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.9 | 10.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.9 | 5.2 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.9 | 24.8 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.8 | 2.5 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.8 | 3.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.8 | 4.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.8 | 13.3 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.8 | 2.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.8 | 15.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.8 | 2.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.8 | 3.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.8 | 18.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.8 | 14.4 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.8 | 6.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.8 | 0.8 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.8 | 2.3 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.8 | 6.2 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.8 | 1.5 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.8 | 3.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.8 | 3.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.8 | 7.6 | GO:1901678 | heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
0.8 | 2.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.8 | 3.0 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.8 | 30.9 | GO:0007628 | adult walking behavior(GO:0007628) |
0.8 | 6.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.7 | 9.7 | GO:0034389 | lipid particle organization(GO:0034389) |
0.7 | 4.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.7 | 11.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.7 | 9.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.7 | 2.2 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.7 | 8.1 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.7 | 2.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.7 | 10.8 | GO:0071625 | vocalization behavior(GO:0071625) |
0.7 | 2.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.7 | 6.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.7 | 26.0 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.7 | 6.3 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.7 | 8.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.7 | 2.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.7 | 0.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.7 | 2.7 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.7 | 6.8 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.7 | 12.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.7 | 2.0 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.7 | 6.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.7 | 3.3 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.6 | 40.8 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.6 | 1.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.6 | 3.2 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.6 | 4.5 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
0.6 | 5.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.6 | 4.4 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.6 | 13.1 | GO:0060384 | innervation(GO:0060384) |
0.6 | 6.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.6 | 10.9 | GO:0051593 | response to folic acid(GO:0051593) |
0.6 | 1.8 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.6 | 9.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.6 | 2.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.6 | 2.4 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.6 | 9.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.6 | 3.5 | GO:0031427 | response to methotrexate(GO:0031427) |
0.6 | 5.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.6 | 8.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.6 | 6.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.6 | 1.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.6 | 6.3 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.6 | 14.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 3.4 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.6 | 10.8 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.6 | 10.2 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.6 | 3.9 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.6 | 3.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.6 | 5.6 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.6 | 3.9 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.6 | 2.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.6 | 2.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.6 | 11.0 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.5 | 6.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.5 | 15.9 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.5 | 12.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.5 | 6.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.5 | 23.2 | GO:0021762 | substantia nigra development(GO:0021762) |
0.5 | 4.3 | GO:0042711 | maternal behavior(GO:0042711) |
0.5 | 5.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.5 | 6.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.5 | 39.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.5 | 16.9 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.5 | 21.1 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.5 | 9.5 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.5 | 4.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.5 | 4.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.5 | 8.9 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.5 | 7.3 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.5 | 60.7 | GO:0007612 | learning(GO:0007612) |
0.5 | 2.6 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.5 | 4.1 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.5 | 3.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.5 | 5.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.5 | 4.4 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.5 | 1.0 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.5 | 3.8 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.5 | 10.0 | GO:0048240 | sperm capacitation(GO:0048240) |
0.5 | 12.4 | GO:0001893 | maternal placenta development(GO:0001893) |
0.5 | 18.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.5 | 12.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 32.4 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.4 | 4.5 | GO:0016559 | peroxisome fission(GO:0016559) |
0.4 | 1.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.4 | 1.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 38.9 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.4 | 3.8 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.4 | 4.8 | GO:0046689 | response to mercury ion(GO:0046689) |
0.4 | 1.6 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.4 | 4.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.4 | 2.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.4 | 2.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.4 | 8.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.4 | 1.1 | GO:0098749 | cerebellar neuron development(GO:0098749) |
0.4 | 3.0 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.4 | 5.9 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.4 | 1.8 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.4 | 1.1 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
0.4 | 2.9 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) |
0.4 | 1.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 8.8 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.3 | 1.0 | GO:0006431 | methionyl-tRNA aminoacylation(GO:0006431) |
0.3 | 3.3 | GO:0007135 | meiosis II(GO:0007135) positive regulation of meiotic nuclear division(GO:0045836) |
0.3 | 1.0 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.3 | 13.1 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.3 | 0.7 | GO:1903373 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) positive regulation of endoplasmic reticulum tubular network organization(GO:1903373) |
0.3 | 2.6 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 0.6 | GO:0015746 | citrate transport(GO:0015746) |
0.3 | 2.2 | GO:0070417 | cellular response to cold(GO:0070417) |
0.3 | 0.9 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 3.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.3 | 0.9 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.3 | 1.3 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.3 | 2.5 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.3 | 4.0 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.3 | 1.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.3 | 7.8 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.3 | 2.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.3 | 16.9 | GO:0046677 | response to antibiotic(GO:0046677) |
0.3 | 0.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 1.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.3 | 12.0 | GO:0050808 | synapse organization(GO:0050808) |
0.3 | 1.6 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.3 | 7.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.3 | 0.8 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.3 | 2.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.3 | 8.9 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 0.8 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.2 | 19.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 1.5 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 3.4 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.2 | 12.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 4.5 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.2 | 2.0 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.2 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.2 | 5.6 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.2 | 5.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.2 | 1.9 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 0.6 | GO:0010694 | regulation of alkaline phosphatase activity(GO:0010692) positive regulation of alkaline phosphatase activity(GO:0010694) |
0.2 | 0.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 1.2 | GO:0019673 | dolichol metabolic process(GO:0019348) GDP-mannose metabolic process(GO:0019673) |
0.2 | 2.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 1.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 1.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 3.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 1.2 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.2 | 2.1 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.2 | 4.6 | GO:0051693 | actin filament capping(GO:0051693) |
0.2 | 2.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 1.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 2.5 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 2.8 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 2.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 2.5 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.2 | 0.2 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.2 | 14.5 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.2 | 0.5 | GO:0016598 | protein arginylation(GO:0016598) |
0.2 | 2.0 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 13.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 1.3 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 1.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 7.8 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.2 | 2.6 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 6.0 | GO:0046847 | filopodium assembly(GO:0046847) |
0.2 | 1.4 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.2 | 1.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 14.6 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.2 | 2.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 4.5 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.2 | 0.9 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 4.7 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.2 | 1.4 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.2 | 0.9 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 1.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 1.8 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 3.0 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 2.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 1.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 4.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 1.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 2.4 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 2.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 2.0 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 2.4 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 6.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 2.3 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 5.4 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 0.7 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 11.3 | GO:0007601 | visual perception(GO:0007601) |
0.1 | 0.9 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 2.4 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.1 | 9.8 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.1 | 6.5 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 | 0.5 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 1.8 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.1 | 5.6 | GO:1990748 | cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.1 | 0.8 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.1 | 1.9 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 3.8 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.1 | 1.6 | GO:0097009 | energy homeostasis(GO:0097009) |
0.1 | 0.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 4.9 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.1 | 11.2 | GO:0000398 | RNA splicing, via transesterification reactions(GO:0000375) RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 9.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 1.7 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.1 | 0.6 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 4.2 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.1 | 0.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.5 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.7 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 1.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 1.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 5.8 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 1.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 2.4 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 27.4 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.4 | 46.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
12.1 | 36.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
9.3 | 37.1 | GO:0044307 | dendritic branch(GO:0044307) |
6.3 | 125.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
6.2 | 37.5 | GO:0033269 | internode region of axon(GO:0033269) |
5.8 | 17.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
5.6 | 44.7 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
5.4 | 16.3 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) GABA-ergic synapse(GO:0098982) |
4.3 | 13.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
4.2 | 16.9 | GO:0097513 | myosin II filament(GO:0097513) |
4.2 | 12.6 | GO:0043511 | inhibin-betaglycan-ActRII complex(GO:0034673) inhibin complex(GO:0043511) |
4.1 | 12.3 | GO:0060187 | cell pole(GO:0060187) |
3.5 | 20.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
3.2 | 9.6 | GO:0097444 | spine apparatus(GO:0097444) |
3.2 | 15.8 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
3.0 | 21.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
3.0 | 9.0 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
3.0 | 8.9 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
2.9 | 43.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
2.8 | 50.5 | GO:0033268 | node of Ranvier(GO:0033268) |
2.7 | 13.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
2.6 | 28.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
2.3 | 7.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
2.3 | 37.0 | GO:0031045 | dense core granule(GO:0031045) |
2.3 | 9.0 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
2.1 | 6.3 | GO:0045203 | intrinsic component of cell outer membrane(GO:0031230) integral component of cell outer membrane(GO:0045203) |
2.1 | 16.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.7 | 5.2 | GO:0098855 | HCN channel complex(GO:0098855) |
1.7 | 5.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
1.5 | 19.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.4 | 41.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.4 | 5.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.4 | 4.1 | GO:0045242 | mitochondrial isocitrate dehydrogenase complex (NAD+)(GO:0005962) isocitrate dehydrogenase complex (NAD+)(GO:0045242) |
1.4 | 43.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.4 | 42.0 | GO:0097440 | apical dendrite(GO:0097440) |
1.3 | 38.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.3 | 9.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
1.3 | 6.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.2 | 97.2 | GO:0030315 | T-tubule(GO:0030315) |
1.2 | 22.9 | GO:0033391 | chromatoid body(GO:0033391) |
1.1 | 14.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.0 | 41.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.0 | 69.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
1.0 | 6.0 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
1.0 | 7.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.9 | 3.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.9 | 39.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.9 | 4.5 | GO:0043293 | apoptosome(GO:0043293) |
0.9 | 79.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.9 | 2.6 | GO:1990037 | Lewy body core(GO:1990037) |
0.9 | 16.3 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.8 | 11.8 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.8 | 8.4 | GO:0045180 | basal cortex(GO:0045180) |
0.8 | 2.4 | GO:0043196 | varicosity(GO:0043196) |
0.8 | 0.8 | GO:0090534 | calcium ion-transporting ATPase complex(GO:0090534) |
0.8 | 9.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.8 | 3.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.8 | 3.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.7 | 10.1 | GO:0030673 | axolemma(GO:0030673) |
0.7 | 5.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.7 | 5.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.7 | 5.0 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.7 | 53.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.7 | 7.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 2.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.7 | 43.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.7 | 6.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.6 | 6.4 | GO:0060091 | kinocilium(GO:0060091) |
0.6 | 22.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 121.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.6 | 13.2 | GO:0005922 | connexon complex(GO:0005922) |
0.6 | 16.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 2.5 | GO:0045252 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.6 | 5.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.6 | 1.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.6 | 4.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.6 | 3.5 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.6 | 2.3 | GO:0032044 | DSIF complex(GO:0032044) |
0.6 | 12.7 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.6 | 5.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.6 | 15.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.6 | 34.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.6 | 13.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.6 | 24.2 | GO:0014704 | intercalated disc(GO:0014704) |
0.5 | 1.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.5 | 2.7 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.5 | 3.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.5 | 4.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.5 | 64.0 | GO:0043204 | perikaryon(GO:0043204) |
0.5 | 2.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 4.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 1.9 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.4 | 1.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.4 | 22.3 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.4 | 2.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 2.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 2.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.4 | 1.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.4 | 2.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.4 | 4.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.4 | 2.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.4 | 10.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 1.1 | GO:0033557 | Slx1-Slx4 complex(GO:0033557) |
0.4 | 3.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.3 | 12.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.3 | 59.4 | GO:0043209 | myelin sheath(GO:0043209) |
0.3 | 9.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 6.3 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 12.5 | GO:0097060 | synaptic membrane(GO:0097060) |
0.3 | 2.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 28.2 | GO:0043197 | dendritic spine(GO:0043197) |
0.3 | 15.9 | GO:0005844 | polysome(GO:0005844) |
0.3 | 2.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 10.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 7.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.3 | 10.0 | GO:0031672 | A band(GO:0031672) |
0.3 | 0.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 16.7 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.3 | 6.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.3 | 41.4 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.2 | 83.8 | GO:0043025 | neuronal cell body(GO:0043025) |
0.2 | 0.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 2.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 4.3 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 4.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 4.7 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 1.9 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 3.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 4.2 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.2 | 1.6 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.2 | 1.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 3.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 1.9 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 12.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 6.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 5.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 18.2 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 0.4 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.1 | 0.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 2.6 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 1.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 2.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 2.6 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 5.7 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 1.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 7.3 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 1.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.8 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 3.0 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 1.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 1.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.1 | 85.6 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
8.0 | 40.1 | GO:1904315 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
7.0 | 20.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
6.8 | 20.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
6.6 | 19.8 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
6.2 | 49.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
5.9 | 23.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
5.7 | 17.2 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
5.7 | 28.7 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
5.6 | 16.7 | GO:0031997 | N-terminal myristoylation domain binding(GO:0031997) calcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099567) |
5.3 | 15.9 | GO:0001847 | opsonin receptor activity(GO:0001847) |
5.0 | 25.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
5.0 | 14.9 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
4.9 | 14.7 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
4.6 | 18.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
4.5 | 27.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
4.4 | 13.3 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
4.1 | 16.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
4.1 | 12.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
4.0 | 19.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.9 | 3.9 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
3.9 | 15.4 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) palmitoyl-CoA 9-desaturase activity(GO:0032896) |
3.8 | 46.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
3.8 | 15.1 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
3.5 | 10.6 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
3.5 | 10.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
3.5 | 24.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
3.5 | 13.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
3.4 | 3.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
3.4 | 10.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
3.3 | 16.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
3.3 | 13.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
3.1 | 15.7 | GO:0097016 | L27 domain binding(GO:0097016) |
3.1 | 37.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
3.1 | 12.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
3.1 | 9.2 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
3.0 | 12.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
3.0 | 9.1 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
3.0 | 12.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
2.9 | 11.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
2.7 | 27.3 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
2.6 | 26.4 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
2.6 | 10.5 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
2.6 | 18.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.6 | 18.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
2.5 | 10.2 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
2.5 | 7.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
2.5 | 24.7 | GO:0003680 | AT DNA binding(GO:0003680) |
2.5 | 17.2 | GO:0048495 | Roundabout binding(GO:0048495) |
2.4 | 19.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
2.3 | 14.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
2.3 | 16.3 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.3 | 13.7 | GO:0005499 | vitamin D binding(GO:0005499) |
2.3 | 9.0 | GO:0008489 | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity(GO:0008489) |
2.3 | 49.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
2.2 | 53.5 | GO:0005112 | Notch binding(GO:0005112) |
2.2 | 66.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
2.2 | 8.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
2.2 | 2.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
2.2 | 6.5 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) uptake transmembrane transporter activity(GO:0015563) |
2.2 | 49.5 | GO:0031489 | myosin V binding(GO:0031489) |
2.2 | 25.8 | GO:0050897 | cobalt ion binding(GO:0050897) |
2.1 | 14.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
2.1 | 12.6 | GO:0034711 | inhibin binding(GO:0034711) |
2.1 | 6.3 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
2.1 | 18.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.0 | 13.7 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
1.9 | 7.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
1.9 | 5.8 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
1.9 | 9.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.8 | 11.1 | GO:0017040 | ceramidase activity(GO:0017040) |
1.8 | 9.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.8 | 8.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.7 | 27.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
1.7 | 20.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.7 | 6.7 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
1.7 | 11.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.7 | 13.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.7 | 5.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.6 | 22.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
1.6 | 21.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.6 | 9.6 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
1.6 | 4.8 | GO:0004829 | proline-tRNA ligase activity(GO:0004827) threonine-tRNA ligase activity(GO:0004829) |
1.6 | 12.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.6 | 4.7 | GO:0009931 | calcium-dependent protein kinase C activity(GO:0004698) calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.6 | 12.4 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
1.5 | 4.6 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
1.5 | 4.5 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
1.5 | 11.9 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
1.4 | 15.7 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.4 | 16.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.4 | 6.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.4 | 4.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.4 | 6.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.3 | 2.7 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
1.3 | 4.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
1.3 | 24.9 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
1.3 | 3.8 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
1.3 | 5.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.3 | 11.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.2 | 3.7 | GO:0038100 | nodal binding(GO:0038100) |
1.2 | 3.7 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
1.2 | 9.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.2 | 8.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.2 | 9.6 | GO:0043559 | insulin binding(GO:0043559) |
1.2 | 4.7 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
1.2 | 4.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.2 | 22.2 | GO:0043274 | phospholipase binding(GO:0043274) |
1.2 | 4.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.1 | 41.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
1.1 | 14.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.1 | 8.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.1 | 25.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
1.1 | 8.8 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.1 | 13.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.1 | 28.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.1 | 3.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.1 | 2.1 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
1.0 | 5.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
1.0 | 4.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.0 | 14.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.0 | 16.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.0 | 7.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.0 | 1.0 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
1.0 | 6.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.0 | 13.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.9 | 5.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.9 | 12.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.9 | 5.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.9 | 19.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.9 | 2.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.9 | 4.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.9 | 4.5 | GO:0001155 | TFIIIA-class transcription factor binding(GO:0001155) |
0.9 | 13.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.9 | 71.8 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.9 | 8.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.9 | 39.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.8 | 7.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.8 | 2.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.8 | 5.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.8 | 34.5 | GO:0032934 | sterol binding(GO:0032934) |
0.8 | 9.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.8 | 4.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.8 | 11.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.8 | 4.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.8 | 25.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.8 | 9.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.8 | 4.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.8 | 3.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.8 | 3.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.8 | 2.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.8 | 37.1 | GO:0019213 | deacetylase activity(GO:0019213) |
0.8 | 4.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.7 | 18.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.7 | 2.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.7 | 10.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.7 | 2.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.7 | 9.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.7 | 4.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.7 | 3.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.7 | 10.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.7 | 18.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.6 | 43.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.6 | 3.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.6 | 2.6 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.6 | 8.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.6 | 13.4 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.6 | 1.3 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.6 | 1.9 | GO:0052724 | inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.6 | 6.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.6 | 5.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.6 | 21.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.6 | 12.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.6 | 6.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.6 | 4.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.6 | 9.0 | GO:0016918 | retinal binding(GO:0016918) |
0.6 | 3.5 | GO:0031404 | chloride ion binding(GO:0031404) |
0.6 | 8.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.6 | 2.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.6 | 14.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.6 | 18.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.6 | 2.8 | GO:0070404 | NADH binding(GO:0070404) |
0.6 | 1.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.6 | 4.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.6 | 5.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.5 | 1.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 17.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 1.6 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.5 | 4.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.5 | 3.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.5 | 6.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.5 | 3.6 | GO:0016595 | glutamate binding(GO:0016595) |
0.5 | 6.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.5 | 3.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.5 | 4.0 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.5 | 13.5 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.5 | 8.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.5 | 7.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 1.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.5 | 2.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.5 | 4.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.5 | 4.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.4 | 15.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.4 | 1.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.4 | 4.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.4 | 3.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 1.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.4 | 3.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 2.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.4 | 2.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.4 | 2.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.4 | 1.6 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.4 | 7.6 | GO:0005537 | mannose binding(GO:0005537) |
0.4 | 6.6 | GO:0042166 | acetylcholine-gated cation channel activity(GO:0022848) acetylcholine binding(GO:0042166) |
0.4 | 6.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.4 | 7.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.4 | 2.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.4 | 1.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.4 | 20.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.4 | 3.7 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 5.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 7.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 1.0 | GO:0004825 | methionine-tRNA ligase activity(GO:0004825) |
0.3 | 14.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.3 | 0.6 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) |
0.3 | 0.9 | GO:0004075 | biotin carboxylase activity(GO:0004075) pyruvate carboxylase activity(GO:0004736) |
0.3 | 18.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 1.2 | GO:0000829 | inositol heptakisphosphate kinase activity(GO:0000829) |
0.3 | 9.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 1.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 5.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 6.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 7.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.3 | 13.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.3 | 25.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.3 | 1.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 19.1 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.3 | 2.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 4.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 5.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 5.2 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.3 | 6.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.3 | 5.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 4.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 3.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 4.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 11.8 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 106.5 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.2 | 3.0 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 5.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 6.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 2.0 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.2 | 22.7 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 2.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 5.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 16.8 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.2 | 1.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 1.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 2.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 3.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 0.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 3.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 1.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 3.7 | GO:0015923 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
0.2 | 69.1 | GO:0003779 | actin binding(GO:0003779) |
0.2 | 1.4 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 0.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 7.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 3.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 0.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 2.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.4 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 10.7 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 12.4 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
0.1 | 1.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 2.8 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 18.1 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 1.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.5 | GO:0010853 | cyclase regulator activity(GO:0010851) cyclase activator activity(GO:0010853) guanylate cyclase regulator activity(GO:0030249) guanylate cyclase activator activity(GO:0030250) |
0.1 | 2.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 4.9 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.1 | 1.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 1.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 1.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 21.4 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 2.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 1.1 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.1 | 0.2 | GO:0016823 | oxaloacetate decarboxylase activity(GO:0008948) hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 2.8 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 1.5 | GO:0050661 | NADP binding(GO:0050661) |
0.0 | 0.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 4.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 27.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 3.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 29.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.4 | 18.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.2 | 4.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.1 | 16.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.1 | 92.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.0 | 7.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.0 | 27.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.8 | 5.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.6 | 26.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 3.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 14.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 14.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.5 | 5.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 14.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 20.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 6.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.4 | 7.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 4.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 23.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 63.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 10.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 6.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 5.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 2.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 7.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 1.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 0.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 4.6 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 5.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 2.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 5.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.0 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 1.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.2 | 135.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
4.5 | 9.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
4.3 | 149.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
3.8 | 56.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
3.6 | 61.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
1.9 | 27.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.7 | 30.7 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
1.7 | 25.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
1.5 | 32.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
1.3 | 29.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.3 | 19.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.3 | 12.6 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
1.1 | 47.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.1 | 21.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
1.1 | 30.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.0 | 14.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.0 | 18.5 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
1.0 | 12.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.9 | 19.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.9 | 21.6 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.9 | 26.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.9 | 11.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.8 | 11.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.7 | 13.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.7 | 5.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.7 | 8.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.7 | 8.7 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.7 | 11.3 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.7 | 11.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.6 | 31.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 12.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.6 | 8.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.6 | 22.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.6 | 13.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.6 | 16.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.5 | 24.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 14.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.5 | 11.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.5 | 38.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.5 | 5.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.5 | 5.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.4 | 6.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.4 | 3.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 11.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.4 | 22.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.4 | 7.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 9.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.4 | 6.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.4 | 8.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 12.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 3.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 5.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 3.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 12.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 2.4 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 10.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 14.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 34.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.3 | 2.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.3 | 3.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 3.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 2.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 5.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 3.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 4.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 6.6 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.1 | 6.9 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 7.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 2.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 3.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 2.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 1.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.5 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 1.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 3.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 1.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |